C82.95

Clinical Causes: The exact cause of follicular lymphoma remains unknown, but it involves genetic mutations that lead to abnormal growth of lymphocytes. Several risk factors have been associated with the development of this lymphoma, including: - Age: Most cases occur in middle-aged and older adults - Gender: Slightly more common in males - Family history: Having a family member with lymphoma increases risk - Environmental exposures: Certain chemicals or prior radiation exposure - Immune system deficiencies: Conditions that weaken the immune response - Recent infections or autoimmune disorders, although less common, Current research continues to explore these and other potential contributors to the development of follicular lymphoma.

Key Symptoms: Follicular lymphoma often grows slowly and may not cause noticeable symptoms in the early stages. When symptoms do appear, they may include: - Painless swelling of lymph nodes in the groin, legs, or other areas - Fatigue - Unexplained weight loss - Fever - Night sweats - A feeling of fullness or discomfort in the abdomen due to enlarged lymph nodes - Sometimes, localized pain or pressure if the lymph nodes press against nearby structures Because these symptoms can be non-specific, they are often initially overlooked or attributed to other less serious conditions.

Diagnosis Path: Diagnosis of follicular lymphoma involves a combination of clinical evaluation and specialized tests: - Physical examination to check for swollen lymph nodes - Blood tests to assess overall health and detect abnormal cells - Imaging studies such as CT scans, PET scans, or MRI to locate enlarged lymph nodes and assess spread - Lymph node biopsy, which remains the definitive method for diagnosis, in which a sample of lymph tissue is examined under a microscope to identify characteristic features - Immunophenotyping and genetic testing to confirm the type and understand specific mutations Early and accurate diagnosis is essential for determining the most appropriate management plan.

Treatment Protocols: Treatment options depend on various factors including disease stage, patient age, overall health, and specific disease characteristics. Common approaches include: - Observation: In some cases with indolent lymphoma, active surveillance may be recommended - Chemotherapy: Often combined with immunotherapy agents - Immunotherapy: Monoclonal antibodies such as rituximab are frequently used - Radiation therapy: For localized disease - Targeted therapies: Drugs that specifically target cancer cell pathways - Stem cell transplant: In certain cases, particularly in relapsed or refractory disease The goal of treatment is to control symptoms, reduce tumor burden, and improve quality of life. Since follicular lymphoma can be indolent but persistent, ongoing follow-up is essential for managing the condition effectively.